Vanguard Group Inc Cassava Sciences Inc Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Cassava Sciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,289,523 shares of SAVA stock, worth $6.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,289,523

Previous 2,170,072 5.5%

Holding current value

$6.32 Million

Previous $3.93 Million 69.65%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$1.85 - $3.41 $220,984 - $407,327	119,451 Added 5.5%	2,289,523 $6.66 Million
Q2 2025 Aug 11, 2025	SELL	$1.19 - $2.24 $323,959 - $609,806	-272,235 Reduced 11.15%	2,170,072 $3.93 Million
Q1 2025 May 09, 2025	SELL	$1.5 - $3.02 $106,767 - $214,957	-71,178 Reduced 2.83%	2,442,307 $3.66 Million
Q4 2024 Feb 11, 2025	SELL	$2.29 - $32.18 $21,326 - $299,692	-9,313 Reduced 0.37%	2,513,485 $5.93 Million
Q3 2024 Nov 13, 2024	SELL	$9.57 - $35.08 $1.53 Million - $5.62 Million	-160,328 Reduced 5.98%	2,522,798 $74.2 Million

Q2 2024 Aug 13, 2024	BUY	$12.35 - $26.11 $4.03 Million - $8.53 Million	326,646 Added 13.86%	2,683,126 $33.1 Million
Q1 2024 May 10, 2024	BUY	$18.44 - $26.41 $587,387 - $841,264	31,854 Added 1.37%	2,356,480 $47.8 Million
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $708,598 - $1.69 Million	56,060 Added 2.47%	2,324,626 $52.3 Million
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $314,612 - $478,725	18,907 Added 0.84%	2,268,566 $37.7 Million
Q2 2023 Aug 14, 2023	BUY	$21.59 - $27.88 $275,358 - $355,581	12,754 Added 0.57%	2,249,659 $55.2 Million
Q1 2023 May 15, 2023	BUY	$23.46 - $36.44 $937,930 - $1.46 Million	39,980 Added 1.82%	2,236,905 $54 Million
Q4 2022 Feb 10, 2023	BUY	$27.82 - $44.16 $2.42 Million - $3.84 Million	87,062 Added 4.13%	2,196,925 $64.9 Million
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $1.01 Million - $3.17 Million	62,151 Added 3.04%	2,109,863 $88.2 Million
Q2 2022 Aug 12, 2022	BUY	$17.22 - $38.47 $1.26 Million - $2.81 Million	72,983 Added 3.7%	2,047,712 $57.6 Million
Q1 2022 May 13, 2022	SELL	$32.6 - $53.05 $2.81 Million - $4.57 Million	-86,090 Reduced 4.18%	1,974,729 $73.3 Million
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $3.18 Million - $7.87 Million	86,537 Added 4.38%	2,060,819 $90.1 Million
Q3 2021 Nov 12, 2021	BUY	$41.79 - $135.3 $6.19 Million - $20 Million	148,079 Added 8.11%	1,974,282 $123 Million
Q2 2021 Aug 13, 2021	BUY	$32.15 - $89.72 $58.7 Million - $164 Million	1,826,203 New	1,826,203 $156 Million

Others Institutions Holding SAVA

# of Institutions

136

Shares Held

15.9M

Call Options Held

1.26M

Put Options Held

791K

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $111M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cassava Sciences Inc Transaction History